[go: up one dir, main page]

AU2002213194A1 - Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation - Google Patents

Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation

Info

Publication number
AU2002213194A1
AU2002213194A1 AU2002213194A AU1319402A AU2002213194A1 AU 2002213194 A1 AU2002213194 A1 AU 2002213194A1 AU 2002213194 A AU2002213194 A AU 2002213194A AU 1319402 A AU1319402 A AU 1319402A AU 2002213194 A1 AU2002213194 A1 AU 2002213194A1
Authority
AU
Australia
Prior art keywords
plasmin
prevention
acting
reduction
adhesion formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213194A
Other languages
English (en)
Inventor
Heinz Redl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of AU2002213194A1 publication Critical patent/AU2002213194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AU2002213194A 2000-10-13 2001-10-12 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation Abandoned AU2002213194A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24043800P 2000-10-13 2000-10-13
US60/240,438 2000-10-13
PCT/US2001/032043 WO2002030445A2 (fr) 2000-10-13 2001-10-12 Fibrinogene plus inhibiteur de fibrinolyse n'agissant pas sur la plasmine pour reduire ou prevenir la formation d'adherences

Publications (1)

Publication Number Publication Date
AU2002213194A1 true AU2002213194A1 (en) 2002-04-22

Family

ID=22906521

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213194A Abandoned AU2002213194A1 (en) 2000-10-13 2001-10-12 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation

Country Status (3)

Country Link
US (1) US7326412B2 (fr)
AU (1) AU2002213194A1 (fr)
WO (1) WO2002030445A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119901B2 (en) 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
IL207586A0 (en) * 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US9655621B2 (en) * 2013-03-15 2017-05-23 Covidien Lp Surgical instrument for dispensing tacks and solution
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US10588998B2 (en) 2015-08-07 2020-03-17 Xcede Technologies, Inc. Adhesive compositions and related methods
WO2025049724A1 (fr) * 2023-08-29 2025-03-06 Board Of Regents Of The University Of Nebraska Compositions et méthodes de traitement d'infections de l'espace pleural et de l'hémothorax

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359652B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
AT366916B (de) * 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
AT379311B (de) * 1984-03-29 1985-12-27 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
AT382783B (de) * 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
AT388503B (de) 1987-05-21 1989-07-25 Immuno Ag Set zur bereitstellung und applikation eines gewebeklebstoffes
SE9101853D0 (sv) * 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
AT406120B (de) * 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
CA2330972C (fr) * 1998-05-01 2008-08-19 Zymogenetics, Inc. Compositions d'adhesif tissulaire entierement recombinantes
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
AU771557B2 (en) * 1999-06-01 2004-03-25 Vivolution A/S Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
WO2002030445A3 (fr) 2003-08-14
WO2002030445A2 (fr) 2002-04-18
US7326412B2 (en) 2008-02-05
US20040043016A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU1624801A (en) Plasminogen activator inhibitor antagonists related applications
AU2381600A (en) Thrombin or factor xa inhibitors
AU2002360983A1 (en) Adhesion inhibition of fungi
AU2002232575A1 (en) Nutritional composition for improving the efficacy of a lipase inhibitor
AU2108601A (en) Salicylamides as serine protease inhibitors
AU1530001A (en) Inhibitor compositions
AU3886799A (en) Growth-associated protease inhibitor heavy chain precursor
AU4092799A (en) Protease inhibitors
AU2002213194A1 (en) Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
AU2002322802A1 (en) Thrombin inhibitors
AUPP982399A0 (en) Mmp inhibitor
AU9110298A (en) Protease inhibitors
AU2002349621A1 (en) Angiogenesis inhibitor
AU2002224550A1 (en) Corrosion inhibitors
AU1588901A (en) Protease inhibitors
AU4564499A (en) Protease inhibitors
AU1474801A (en) Protease inhibitors
AU2002351076A1 (en) Thrombin inhibitors
AU1474701A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors
AU2001283340A1 (en) Factor viia inhibitors
AU2001251057A1 (en) Multi-domain proteinase inhibitor
AU2002342682A1 (en) Protease inhibitors